THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 98 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 6.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,420,394 | -12.8% | 164,588 | +4.6% | 0.00% | 0.0% |
Q2 2023 | $1,628,355 | +96999.3% | 157,329 | +1.8% | 0.00% | 0.0% |
Q1 2023 | $1,677 | -40.7% | 154,510 | -38.7% | 0.00% | 0.0% |
Q4 2022 | $2,828 | -99.8% | 252,047 | +43.1% | 0.00% | 0.0% |
Q3 2022 | $1,787,000 | -17.9% | 176,173 | -26.6% | 0.00% | 0.0% |
Q2 2022 | $2,176,000 | +20.2% | 240,162 | +28.5% | 0.00% | 0.0% |
Q1 2022 | $1,811,000 | +9.7% | 186,906 | +13.4% | 0.00% | – |
Q4 2021 | $1,651,000 | +31.4% | 164,790 | -6.7% | 0.00% | – |
Q3 2021 | $1,256,000 | -53.9% | 176,717 | -5.8% | 0.00% | -100.0% |
Q2 2021 | $2,725,000 | -30.4% | 187,672 | -2.2% | 0.00% | 0.0% |
Q1 2021 | $3,916,000 | +15.9% | 191,887 | +0.9% | 0.00% | 0.0% |
Q4 2020 | $3,379,000 | +9.0% | 190,160 | -9.3% | 0.00% | 0.0% |
Q3 2020 | $3,099,000 | -31.5% | 209,633 | -2.8% | 0.00% | -50.0% |
Q2 2020 | $4,526,000 | -35.2% | 215,653 | -28.6% | 0.00% | -33.3% |
Q1 2020 | $6,982,000 | -0.8% | 302,145 | +11.1% | 0.00% | 0.0% |
Q4 2019 | $7,040,000 | +30.1% | 271,951 | -2.1% | 0.00% | +50.0% |
Q3 2019 | $5,411,000 | +49.9% | 277,791 | +25.6% | 0.00% | +100.0% |
Q2 2019 | $3,610,000 | – | 221,092 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
Baupost Group | 7,419,226 | $64,028 | 1.23% |
Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |